FindTrial
Sign In

5%

DRUG6 trials

Sponsors

Stichting Radboud University Medical Center, Smarthealth Inc., Helse Bergen HF, Centre Hospitalier Universitaire De Rennes, Vrije Universiteit Brussel

Conditions

Allergic contact dermatitisAllergic contact dermatitis EczemaInflammatory response following human endotoxemia in healthy volunteersSevere refractory cancer painVirus Diseasesinflammatory secretions of the conjunctiva (Eye desease)

Phase 2

Immunomodulatory effects of dexamethasone, tocilizumab and anakinra during experimental human endotoxemia: the DEDICATE-LPS study
Active, not recruitingCTIS2023-506556-24-00
Stichting Radboud University Medical CenterInflammatory response following human endotoxemia in healthy volunteers
Start: 2024-10-24Target: 52Updated: 2025-04-28

Phase 3

Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study
WithdrawnCTIS2023-507972-35-00
Smarthealth Inc.Allergic contact dermatitis Eczema
Target: 105Updated: 2024-01-22
Paxlovid long covid-19 prevention trial with recruitment in the community in Norway
Active, not recruitingCTIS2023-510337-29-00
Helse Bergen HFVirus Diseases
Start: 2023-04-11Target: 2000Updated: 2025-05-28
Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study
Not yet recruitingCTIS2023-507972-35-01
Smarthealth Inc.Allergic contact dermatitis
Target: 95Updated: 2025-06-16
CRYSTAL : Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular prostheses
Not yet recruitingCTIS2024-517441-14-00
Centre Hospitalier Universitaire De Rennesinflammatory secretions of the conjunctiva (Eye desease)
Target: 30Updated: 2025-06-05

Phase 4

Intrathecal drug delivery systems versus comprehensive medical management for severe cancer pain: a randomized controlled trial
Not yet recruitingCTIS2025-522381-68-00
Vrije Universiteit BrusselSevere refractory cancer pain
Target: 72Updated: 2026-03-04